Literature DB >> 28509118

Anti-glomerular basement membrane disease accompanied by systemic lupus erythematosus presenting central nervous system involvement.

Hirohito Sugawara1, Hideki Takizawa2, Yoshinosuke Shimamura2, Norihito Moniwa2, Koichi Hasegawa2, Yayoi Ogawa3.   

Abstract

We report a case of rapidly progressive glomerulonephritis caused by anti-glomerular basement membrane (GBM) disease accompanied by systemic lupus erythematosus (SLE) presenting central nervous system involvement in a 32-year-old Japanese male. He was admitted to our hospital because of a 3-week history of fever and rapidly failing renal function requiring hemodialysis (HD). Laboratory tests showed anti-GBM antibody elevation with a value of 16,385 units/ml. On day 85, he had generalized tonic-clonic seizure. Brain magnetic resonance T2 Flair imaging showed multiple high intensity lesions in a broad area. We made a diagnosis of central nervous system involvement in SLE based on positivity for antinuclear and anti-DNA antibodies, hypocomplementemia, and discoid skin rash. After combined therapy consisting of plasma exchange, HD, and steroid pulse, the patient made a good recovery without any residual neurological sequelae, though kidney dysfunction requiring maintenance HD remained. Anti-GBM antibody finally became undetectable on the 144th hospital day.

Entities:  

Keywords:  Anti-glomerular basement membrane disease; Rapidly progressive glomerulonephritis; Systemic lupus erythematosus

Year:  2016        PMID: 28509118      PMCID: PMC5438798          DOI: 10.1007/s13730-016-0233-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  5 in total

1.  Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis.

Authors:  C-H Li; Y-C Li; P-S Xu; X Hu; C-Y Wang; G-L Zou
Journal:  Scand J Rheumatol       Date:  2006 May-Jun       Impact factor: 3.641

2.  The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease.

Authors:  Wataru Kitagawa; Hirokazu Imai; Atsushi Komatsuda; Nobuki Maki; Hideki Wakui; Yoshiyuki Hiki; Satoshi Sugiyama
Journal:  Nephrol Dial Transplant       Date:  2008-04-15       Impact factor: 5.992

3.  Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.

Authors:  Kui Liu; Quan-Zhen Li; Angelica M Delgado-Vega; Anna-Karin Abelson; Elena Sánchez; Jennifer A Kelly; Li Li; Yang Liu; Jinchun Zhou; Mei Yan; Qiu Ye; Shenxi Liu; Chun Xie; Xin J Zhou; Sharon A Chung; Bernardo Pons-Estel; Torsten Witte; Enrique de Ramón; Sang-Cheol Bae; Nadia Barizzone; Gian Domenico Sebastiani; Joan T Merrill; Peter K Gregersen; Gary G Gilkeson; Robert P Kimberly; Timothy J Vyse; Il Kim; Sandra D'Alfonso; Javier Martin; John B Harley; Lindsey A Criswell; Edward K Wakeland; Marta E Alarcón-Riquelme; Chandra Mohan
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

4.  Identical twins:one with anti-glomerular basement membrane glomerulonephritis,the other with systemic lupus erythematosus.

Authors:  Xiaoxia Liu; Yu Wu; Yuan Yang; Jue Wang; Ye Tao; Ping Fu; Zhangxue Hu
Journal:  BMC Nephrol       Date:  2013-12-20       Impact factor: 2.388

5.  Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress.

Authors:  Yajuan Li; Indu Raman; Yong Du; Mei Yan; Soyoun Min; Jichen Yang; Xiangdong Fang; Wei Li; Jianxin Lu; Xin J Zhou; Chandra Mohan; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.